Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 3 | 0 | 0 | 3 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
GLS protein | 2 | 0 | 0 | 2 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
Smad3 | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
progesterone receptor | 2 | 0 | 0 | 2 |
EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
retinoic acid nuclear receptor alpha variant 1 | 1 | 0 | 0 | 1 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 3 | 0 | 0 | 3 |
estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
peroxisome proliferator activated receptor gamma | 4 | 0 | 0 | 4 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 3 | 0 | 3 |
Multidrug resistance-associated protein 4 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 3 | 0 | 3 |
Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
Bile salt export pump | 0 | 5 | 0 | 5 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 4 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Glutamate receptor 2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
GABA theta subunit | 1 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
toxin B | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
GLI family zinc finger 3 | 4 | 0 | 0 | 4 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
Histamine H2 receptor | 2 | 0 | 0 | 2 |
Spike glycoprotein | 5 | 0 | 0 | 5 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Luciferase | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
AR protein | 5 | 0 | 0 | 5 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
67.9K protein | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
arylsulfatase A | 2 | 0 | 0 | 2 |
IDH1 | 2 | 0 | 0 | 2 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 3 | 0 | 0 | 3 |
geminin | 3 | 0 | 0 | 3 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 2 | 3 |
Albumin | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
Cholinesterase | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Caspase-3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 3 | 1 | 12 |
Sialidase | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Neuraminidase | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
Sialidase-4 | 0 | 1 | 0 | 1 |
Sialidase-1 | 0 | 1 | 0 | 1 |
Sialidase-3 | 0 | 1 | 0 | 1 |
Sialidase-2 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
GALC protein | 2 | 0 | 0 | 2 |
TDP1 protein | 3 | 0 | 0 | 3 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Ataxin-2 | 2 | 0 | 0 | 2 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
thioredoxin reductase | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
Carboxypeptidase M | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 4 | 1 | 5 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 1 | 4 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1B | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1E | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 1 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 1 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
pregnane X nuclear receptor | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Interferon beta | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Glycoprotein | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 2 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 2 | 1 | 4 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |